Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Effects of Belatacept and Anticalcineurins on Endothelial Function in Renal Transplant Patients <BELAFENDO>

NCT06291077 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT06291077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06291077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Effects of Belatacept and Anticalcineurins on Endothelial Function in Renal Transplant Patients <BELAFENDO>
Lead sponsor
University Hospital, Rouen
Phase
Phase 4
Overall status
Recruiting
Start date
April 30, 2026
Completion date
February 1, 2029
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney diseases